(NYSE: STE) Steris's forecast annual revenue growth rate of 6% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.98%.
Steris's revenue in 2025 is $5,571,113,000.On average, 4 Wall Street analysts forecast STE's revenue for 2026 to be $579,372,073,192, with the lowest STE revenue forecast at $570,718,590,058, and the highest STE revenue forecast at $584,802,451,244. On average, 4 Wall Street analysts forecast STE's revenue for 2027 to be $610,599,406,239, with the lowest STE revenue forecast at $598,360,963,538, and the highest STE revenue forecast at $622,408,626,880.
In 2028, STE is forecast to generate $658,073,848,144 in revenue, with the lowest revenue forecast at $651,193,294,408 and the highest revenue forecast at $664,954,500,369.